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The regulatory T (Treg) cells restrain immune re-
sponses through suppressor-function elaboration
that is dependent upon expression of the transcrip-
tion factor Foxp3. Despite a critical role for Treg cells
in maintaining lympho-myeloid homeostasis, it re-
mainsunclearwhetherasinglemechanismormultiple
mechanisms of Treg cell-mediated suppression are
operating in vivo and how redundant such mecha-
nisms might be. Here we addressed these questions
by examining the role of the immunomodulatory cyto-
kine IL-10 inTregcell-mediatedsuppression.Analyses
of mice in which the Treg cell-specific ablation of
a conditional IL-10 allele was induced by Cre recom-
binase knocked into the Foxp3 gene locus showed
that although IL-10 production by Treg cells was not
required for the control of systemic autoimmunity, it
was essential for keeping immune responses in
check at environmental interfaces such as the colon
and lungs. Our study suggests that Treg cells utilize
multiple means to limit immune responses. Further-
more, these mechanisms are likely to be nonredun-
dant, in that a distinct suppressor mechanism most
likely plays a prominent and identifiable role at a
particular tissue and inflammatory setting.
INTRODUCTION
A subset of CD4+ T cells known as regulatory T cells is respon-
sible for limiting tissue damage and inflammation associated
with both innate and adoptive immune responses (Miyara and
Sakaguchi, 2007; Shevach et al., 2001). Treg cells represent
a dedicated cell lineage generated in the thymus; their develop-
ment is dependent upon the expression of the transcription fac-
tor Foxp3 (Fontenot et al., 2003; Hori et al., 2003; Khattri et al.,
2003). In mice, Foxp3 is restricted in its expression to Treg cells,546 Immunity 28, 546–558, April 2008 ª2008 Elsevier Inc.and it therefore represents the best marker to date for this cell
subset (Fontenot et al., 2005). Furthermore, genetic deficiency
in Foxp3 leads to a highly aggressive fatal lymphoproliferative
autoimmune disorder affecting multiple organs, and drug-in-
duced ablation of Treg cells in neonatal or adult mice results in
a similar disease (Fontenot and Rudensky, 2005; Kim et al.,
2007). In humans, Foxp3 mutations result in development of an
analogous fatal disorder dubbed IPEX (Immune disregulation,
Polyendocrinopathy, Enteropathy, X-linked). Autoimmune le-
sions associated with the Foxp3 deficiency are characterized
by lymphadenopathy, splenomegaly, and severe pathology of
the skin and gastrointestinal tract, as well as fulminant im-
mune-mediated inflammation of multiple organs, including the
liver, pancreas, muscles, and lungs (Brunkow et al., 2001; Wildin
and Freitas, 2005). Recent studies indicate that Foxp3 expres-
sion is necessary for suppressor function: Genetically marked
cells transcribing the Foxp3 locus and lacking expression of
the Foxp3 protein are unable to suppress immune responses
in vivo and in vitro (Gavin et al., 2007; Lin et al., 2007). Further-
more, ablation of Foxp3 gene expression in mature peripheral
Treg cells results in a loss of suppressor function (Williams and
Rudensky, 2007).
Despite its major significance, Treg cell-mediated suppres-
sion is poorly understood from a mechanistic point of view.
Over the last several years, numerous molecular and cellular
mechanisms of suppression have been proposed in studies uti-
lizing an antibody-mediated blockade of putative effector mole-
cules or adoptive transfers of Treg cells isolated from mice ge-
netically deficient in these molecules. However, the emerging
picture remains confusing because none of the mechanisms
have been unequivocally proven to operate in un-manipulated
animals. Furthermore, it is not clear whether a single unique
mechanism can account for various manifestations of Treg cell
suppression or whether multiple mechanisms are needed for
suppression to commence. It is also unknown whether distinct
suppression mechanisms, either singly or cooperatively, control
a particular type of inflammation in a specific location. For ex-
ample, in vitro studies unequivocally demonstrated a requirement
for cell-cell-contact-dependent Treg cell-mediated suppression
and excluded a role for IL-10 and TGF-b, two major cytokines
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function (Kullberg et al., 2005; Shevach et al., 2001; von
Boehmer, 2005). In contrast, some in vivo studies suggested
a role for TGF-b1 and IL-10 as effector molecules of Treg cell-
mediated suppression of colitis (Asseman et al., 1999; Fahlen
et al., 2005; Li et al., 2007; Powrie et al., 1996). However, both
cytokines were found to be nonessential for in vivo suppression
of autoimmune gastritis (Shevach et al., 2001). The studies im-
plicating IL-10 in Treg-mediated suppression relied on adoptive
transfer of CD25+CD4+ Treg cells isolated from IL-10-deficient
donor mice and cotransferred with naive or immune CD4+ T
cells into lymphopenic hosts. A caveat for this experimental ap-
proach is that the inflammation induced by transferred T cells is
greatly facilitated by their proliferation under lymphopenic con-
ditions. In addition, lymphopenic conditions might not favor IL-
10 production by ‘‘effector’’ nonregulatory T cells. The latter
cells were shown to serve as a major source of IL-10 in some
parasitic infections in mice and humans (Anderson et al.,
2007; Jankovic et al., 2007; Nylen et al., 2007). Furthermore,
contaminating IL-10-producing Foxp3-negative T cells are pres-
ent at a low frequency in the splenic and lymph node
CD25-CD4+ T cell populations used in a numerous transfer ex-
periments (Kamanaka et al., 2006; Maynard et al., 2007). In ad-
dition, Foxp3-negative T cell populations, including the IL-10-
expressing cell subset, are likely to have inferior proliferative po-
tential compared to that of regulatory Foxp3+ T cells capable of
a very robust expansion in lymphopenic hosts (Gavin et al.,
2002; Komatsu and Hori, 2007). Together, these considerations
make it possible to hypothesize that, in unmanipulated animals,
Foxp3-negative T cells might represent a key source of IL-10. Fi-
nally, in mice with a targeted insertion of the GFP coding se-
quence into the Foxp3 gene locus and a concomitant disruption
of Foxp3 protein expression, we found that GFP+ T cells ex-
pressing this Foxp3null allele express high amounts of IL-10
mRNA and protein, yet lacked suppressor function (Gavin
et al., 2007). Thus, the role for IL-10 as a suppressor molecule
elaborated by Foxp3+ Treg cells to control immune inflammation
remains uncertain.
To directly investigate a role for IL-10 in Treg cell-mediated
suppression, we generated Foxp3YFP-Cre mice, capable of Treg
cell-specific inactivation of genes of interest, and crossed them
with Il10flox/flox mice harboring a conditional Il10 allele. We found
that the selective disruption of IL-10 expression in Treg cells led
to spontaneous colitis. Furthermore, Il10flox/flox 3 Foxp3YFP-Cre
mice developed substantially augmented immune-response-
associated inflammation and pathology in the skin and lungs.
Thus, in unmanipulated animals, IL-10 produced by Treg cells
plays an important role in suppressing immune inflammation at
environmental interfaces. These results strongly suggest that
Treg cells utilize multiple suppression mechanisms to control
various aspects of inflammation, which is mediated by distinct
immune cell types in different settings, and that a deficiency in
any single mechanism of suppression is unlikely to be equivalent
to a complete lack of regulatory T cells. Furthermore, our data
suggest that specificmechanisms of suppression do not operate
in a completely redundant fashion and that these mechanisms,
upon elucidation of their distinct contribution to Treg cell-
mediated suppression, canbeharnessed for potential therapeutic
interventions.RESULTS
Generation and Characterization of Foxp3YFP-Cre Mice
To generate mice capable of selective gene inactivation in Treg
cells, we utilized gene targeting to insert the DNA sequence
coding for a viral IRES followed by YFP-Cre recombinase fusion
protein into the 30 UTR of the Foxp3 locus (Figure 1A). Chimeric
males harboring the targeted Foxp3YFP-Cre allele were bred with
female mice expressing the FLPe recombinase transgene to
excise the Neor cassette and to confirm germ-line transmission
of the targeted allele (Figure 1B). The Neor-negative progeny
was crossed to C57BL/6 mice, and the resulting Foxp3YFP-Cre
mice were analyzed for expression of the YFP-Cre and Foxp3
protein (Figure 1C). The YFP-Cre fusion protein expression
was limited to Treg cells. To examine the specificity of Cre-
mediated recombination in Foxp3YFP-Cre mice, we introduced
the ROSA26YFP (R26Y) recombination reporter allele into these
mice. This allele allowed for the detection of Cre-mediated
recombination at a single-cell level through flow-cytometric
analyses of YFP expression induced upon Cre-mediated exci-
sion of a ‘‘floxed’’ transcriptional stop cassette preceding the
YFP coding sequence inserted into the ubiquitously expressed
ROSA26 locus. Because the YFP reporter expression was mark-
edly higher than that of the YFP-Cre fusion protein, essentially
100% efficient Cre-mediated recombination in Foxp3YFP-Cre
Treg cells was readily ascertained upon costaining for CD4,
CD8, and Foxp3. In addition, individual Foxp3YFP-Cre mice ex-
hibited varying degrees (2%–10%) of R26Y recombination in
different hematopoietic lineage cells that lacked detectable
YFP-Cre and Foxp3 expression; such cells included immature
and mature B cells, T cells, myeloid cells, and bone marrow pre-
cursor cells (Figure S1; data not shown). This was probably due
to stochastic recombination events resulting from a basal level of
Foxp3YFP-Cre transcription, consistent with the emerging data on
the pervasive transcription of genes, including ‘‘silent’’ genes
and non-coding sequences in addition to actively transcribed
genes, involved in developmental processes within the genome
(Guenther et al., 2007). However, the ‘‘off-target’’ recombination
in Foxp3YFP-Cre mice was probably negligible in light of the fact
that a recombination event affecting a single R26Y allele resulted
in YFP expression, whereas ablation of a ‘‘floxed’’ gene of
interest in homozygous configuration required deletion of both
alleles.
Il10 Ablation in Treg Cells Does Not Perturb Their
Development or Result in Systemic Autoimmunity
To generate mice in which the IL-10 deficiency was limited to
Treg cells, we bred Il10flox/flox mice harboring loxP sites flanking
the first exon of the Il10 gene with Foxp3YFP-Cre mice. Genomic
PCR-based examination of the wild-type (Il10WT) as well as
‘‘floxed’’ intact (Il10flox) and recombined (Il10D) alleles of the
Il10 gene in FACS-purified YFP+CD4+ and YFP-CD4+ T cells
showed a highly efficient deletion in YFP+CD4+ T cells, i.e.,
Foxp3+ Treg cells, in male Il10flox/flox3 Foxp3YFP-Cre hemizygous
mice, whereas the Il10D allele was undetectable in YFP
‘‘non-Treg’’ CD4+ T cells (see sorting gate in Figure S2). In addi-
tion, similar analysis of heterozygote Il10flox/WT Foxp3YFP-Cre
mice reveals both the intact Il10flox and Il10WT alleles in YFP-
Cre non-Treg cells, whereas YFP-Cre+ Treg cells containedImmunity 28, 546–558, April 2008 ª2008 Elsevier Inc. 547
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(A) The targeting strategy and map of the Foxp3YFP-Cre construct.548 Immunity 28, 546–558, April 2008 ª2008 Elsevier Inc.
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allele deletion to be at least 90% in YFP+ cells and undetectable
in YFP cells (Figure 2B). To test the specificity of Il10flox allele
deletion at the protein level, we stimulated splenocytes from
Il10flox/flox 3 Foxp3YFP-Cre and littermate control Il10flox/WT 3
Foxp3YFP-Cre mice in vitro and stained them intracellularly with
Foxp3 and IL-10 antibodies (Figure S3A). We observed that
IL-10-producing cells were greatly diminished within the
Foxp3-expressing, but not Foxp3-negative, CD4+ T cell subset.
Male Il10fl/fl3Foxp3YFP-Creandfemale Il10fl/fl3Foxp3YFP-Cre/YFP-Cre
mice were born at a Mendelian frequency and lacked spleno-
megaly, lymphadenopathy or other detectable signs of auto-
immune pathology up to 8 weeks of age (Figure 2C). Flow-cyto-
metric analysis of mutant mice revealed numerically unaltered
thymic and peripheral CD8+ and CD4+ T cell subsets,
including Foxp3+ T cell subsets (Figure 2D). Further examination
of the expression of several T cell activation markers on the
surface of CD4+ T cells isolated from the lymph nodes, spleens,
and mesenteric lymph nodes of mutant and control mice did not
reveal noticeable differences (Figure 2E). IL-2, IL-4, IFN-g, and
TNF-a production by CD4+ T cells was also unaffected in 6- to
8-week-old Il10flox/flox 3 Foxp3YFP-Cre mice (Figure 2F). These
observations were consistent with the largely intact suppressor
capacity of Treg cells in these mice; a complete Treg cell
deficiency due to loss-of-function or null Foxp3 mutations or
due to drug-induced ablation of the Treg cell subset results in
a massive boost of cytokine production by T cells and lym-
phoproliferation. In agreement with these results, we failed to
observe major signs of tissue pathology upon histologic
examination of various organs of un-manipulated Il10flox/flox 3
Foxp3YFP-Cre mice, except for colon inflammation in older ani-
mals (see below). These results suggest that IL-10 expression
by Treg cells is not essential for their requisite role in restraining
early-onset systemic autoimmunity.
Il10flox/flox 3 Foxp3YFP-Cre Mice Develop Spontaneous
Colitis
It has been shown that mice with the germ-line (Il10/) or T cell-
specific ablation of the Il10 gene (Il10flox/flox3 CD4-Cre) develop
spontaneous inflammation in the intestine, in whichHelicobacter
sp. plays a prominent role. In one study, up to 40% of Il10/
mice and a slightly smaller percentage of Il10fl/fl 3 CD4-Cre
mice 6 months of age or older developed rectal prolapse indica-
tive of severe colitis that showed some similarity to inflammatory
bowel disease in human patients (Roers et al., 2004). To examine
whether Treg cell-specific deficiency in IL-10 results in
spontaneous colitis, we monitored a cohort of Il10flox/flox 3
Foxp3YFP-Cre and littermate control Il10flox/WT 3 Foxp3YFP-Cre
mice for clinical signs of colitis, including rectal prolapse and
diarrhea. As a positive control in these experiments, we used
a cohort of Il10/ mice. We found that starting at 10 weeks of
age, Il10flox/flox 3 Foxp3YFP-Cre animals, but not the control
group, presented with gross manifestations of colitis. Uponfurther examination of the affected animals, we found diffuse
colonic thickening and a substantial increase in the size of the
mesenteric lymph nodes and the spleen (data not shown).
Blinded histological evaluation of sections of the stomach and
the small and large intestine from the Il10flox/flox 3 Foxp3YFP-Cre
mice showed that although the stomach and small intestine
were not affected by IL-10 deficiency in Treg cells when these
mice were compared to control mice, the large intestine, espe-
cially the cecum, showed prominent mononuclear infiltration
of epithelial tissue as well as tissue destruction (Figures 3A
and 3B). Colonic inflammation observed in Il10flox/flox 3
Foxp3YFP-Cre mice was histologically similar to that observed
in Il10/ mice, albeit that in the latter experimental group, the
inflammation was more profuse and affected the entire length
of the colon (Figures 3A and 3B). In agreement with microscopic
observations, the onset of the disease was slightly delayed and
the incidence was somewhat lower in Il10flox/flox 3 Foxp3YFP-Cre
mice as compared to Il10/ mice (Figure 3C). It seems unlikely
that the observed differences were due to distinct flora in mice of
different genotypes because they were cohoused and fecal
samples from every experimental group tested positive for
H. hepaticus, H rodentum and H. trogonum by PCR, whereas
H. bilis and H. typhlonus were not detected. Colitis observed in
Il10flox/flox 3 Foxp3YFP-Cre mice was not due to a paucity of
Treg cells in the colon; flow-cytometric analysis of the colonic
T cell population comprised of both intraepithelial lymphocytes
(IEL) and lamina propria lymphocytes (LPL) showed an increased
size of the Foxp3+ Treg cell subset with unaltered Foxp3 expres-
sion on a per-cell basis in Il10flox/flox 3 Foxp3YFP-Cre mice, as
compared to the control Il10WT/flox 3 Foxp3YFP-Cre mice
(Figure 3D). Thus, IL-10 deficient Treg cells are abundant in
the colonic tissue but are unable to restrain inflammation. It
was also possible that inability of Foxp3-expressing cells to pro-
duce IL-10 in the gut might prevent IL-10 secretion by Foxp3-
T cells. To examine this possibility, we isolated LPL from
Il10flox/flox 3 Foxp3YFP-Cre and control Il10WT/flox 3Foxp3YFP-Cre
mice and assessed their ability to produce IL-10 upon in vitro
stimulation. IL-10 producing Foxp3 LPL were readily detect-
able, whereas Foxp3+ LPL were lacking (Figure S3B in the Sup-
plemental Data). A moderate, less-than-two-fold reduction in
the proportion of IL-10-producing cells could be a result of the
inflammatory environment and overall increased T cell infiltration
of the tissue. These data together suggest that IL-10 produced
by Treg cells plays an important role in restraining local inflam-
mation in the colon.
Heightened Immune-Mediated Lung Hyperreactivity
in Il10flox/flox 3 Foxp3YFP-Cre Mice
Although the aforementioned histological examination of
multiple organs and tissues (heart, skeletal muscle, stomach,
pancreas, small intestine, thyroid, and brain) isolated from
Il10flox/flox 3 Foxp3YFP-Cre mice did not reveal noticeable
pathology, we observed mild perivasculitis and moderate(B) Southern-blot analysis of DNA isolated from an ES cell clone with the targeted Foxp3YFP-Cre allele. Genomic DNA was digested withBspHI restriction enzyme,
separated in the agarose gel, and hybridized with a 32P-labeled probe specific for the region indicated in (A). Lane 1, untargeted control ES cell clone; lane 2,
targeted ES cell clone used for generation of the knock-in mice.
(C) Flow-cytometric analysis of T cell subsets in Foxp3YFP-Cre mice. Thymocytes, splenocytes, and lymph node cells isolated from 4- to 6-week-old mice were
stained for CD4, CD8, CD25, and Foxp3. Twelve mice were analyzed in three independent experiments.Immunity 28, 546–558, April 2008 ª2008 Elsevier Inc. 549
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Treg Cell-Derived IL10 Limits InflammationFigure 2. Lack of Systemic Autoimmunity and Normal Development of Treg Cells in Mice with the IL-10 Deficiency Limited to Treg Cells
(A) Deletion of the Il10 gene in Il10flox/flox3 Foxp3YFP-Cre mice is restricted to the Foxp3+ Treg cell subset. PCR-based analysis of YFP-Cre+ and YFP-Cre CD4+
T subsets for the presence of wild-type (Il10WT) and conditional undeleted (Il10flox) or deleted (Il10D) Il10 alleles. Genomic DNA was isolated from the550 Immunity 28, 546–558, April 2008 ª2008 Elsevier Inc.
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Il10flox/flox 3 Foxp3YFP-Cre but not from the littermate control
Il10WT/flox 3 Foxp3YFP-Cre mice (Figure 4A). Flow-cytometric
analysis of T cell populations isolated from perfused lungs
showed an unaltered Foxp3+ T cell subset in Il10flox/flox 3
Foxp3YFP-Cre as compared to Il10WT/flox 3 Foxp3YFP-Cre mice
(Figure 4B). Importantly, approximately 12% of Foxp3+ T cells
in the lungs express IL-10 based on analysis of IL-10 reporter
mice (Maynard and Weaver, personal communication). These
initial observations suggested that IL-10 produced by Treg cells
might play a role in restraining lung inflammation. However, pre-
vious studies utilizing germ-line IL-10-deficient mice in an exper-
imental model of asthma implicated this cytokine in accentuating
the lung pathology downstream of the inflammatory reaction. In
these experiments, Il10/mice sensitized with ovalbumin (OVA)
presented with greatly diminished airway hyperreactivity despite
lung lymphocyte infiltration and eosinophilia comparable to
those observed in wild-type mice upon intranasal OVA challenge
(Makela et al., 2000). Therefore, we tested the role for IL-10
produced by Treg cells in OVA-induced lung inflammation in
Il10flox/flox 3 Foxp3YFP-Cre and in littermate control Il10WT/flox 3
Foxp3YFP-Cre mice. To better account for the potential exacerba-
tion of lung hyperreactivity due to IL-10 deficiency in Treg cells,
we utilized the previously described suboptimal regimen of OVA
immunization to minimize the induced lung inflammation in the
wild-type control group of mice (Henderson et al., 1996; Zhang
et al., 1997). Twenty-four hours after the final intranasal chal-
lenge, we found augmented inflammation manifested by an
approximately 2.7-fold increase in leukocyte numbers in the
bronchoalveolar lavage (BAL) fluid recovered from OVA-treated
Il10flox/flox 3 Foxp3YFP-Cre as compared to littermate control
Il10WT/flox 3 Foxp3YFP-Cre mice (Figure 5A). In addition, histolog-
ical examination, combined with the morphometry of the lung
tissue of the mutant mice, showed markedly increased mucus
production, goblet cell expansion, and edema and an increased
mass of the cellular infiltrates associated with the increased
eosinophilic infiltration around major airways (Figure 5B and
Table 1). In agreement with these results, quantitative real-time
PCR analysis of lung tissue mRNA isolated from OVA-treated
Il10flox/flox 3 Foxp3YFP-Cre animals revealed no marked changes
in IL-4 but increased amounts of IL-5, IL-13, and IFN-g mes-
sages when these mice were compared to OVA-sensitized con-
trol mice (Figure S4; data not shown). These results were also
consistent with the ELISA analysis of the corresponding cyto-kines in the lung-tissue extracts of OVA-immunized and chal-
lenged Il10flox/flox 3 Foxp3YFP-Cre (data not shown). To further
evaluate functional consequences of lung inflammation ob-
served by histological means and analyses of BAL cell content,
we measured lung resistance by using invasive plethysmogra-
phy. Consistent with the utilization of the OVA sensitization and
challenge protocol for induction of suboptimal lung inflammation
in the wild-type mice, neither the OVA- nor the saline-treated
Il10WT/flox 3 Foxp3YFP-Cre control mice showed a marked in-
crease in airway hyperreactivity to aerosolized methacholine.
However, we found greatly augmented airway hyperreactivity
in response to inhaled methacholine in OVA-treated mice but
not in saline-treated Il10flox/flox 3 Foxp3YFP-Cre mice (Figure 5C).
The increased inflammation in the lungs of the mutant mice was
not a consequence of decreased numbers of IL-10-deficient
Treg cells in the inflamed lung tissue because increased size
of the lung Foxp3+ Treg cell subset was found in mutant OVA-
challenged mice (Figure S5). Thus, as in the inflamed colonic
tissue, IL-10-deficient Treg cells are present in the lungs in
increased numbers; however, they fail to provide complete pro-
tection against excessive inflammatory responses initiated by
the airborne antigen. Taken together, our data show that IL-10
secretion by Treg cells, in addition to its role in restraining
immune-mediated inflammation in the colon, is contributing to
Treg cell-mediated suppression of immunological reactivity in
the airways.
Increased Skin Hypersensitivity
in Il10flox/flox 3 Foxp3YFP-Cre Mice
Because we found that the IL-10 production by Treg cells plays
a substantial anti-inflammatory role in the lungs and colon, we
decided to examine whether immune-mediated inflammation is
also affected by the IL-10 deficiency in Treg cells at a third major
environmental interface, the skin. Initial examination of skin sec-
tions from Il10flox/flox3 Foxp3YFP-Cre mice failed to reveal notice-
able mononuclear infiltration or skin thickening typical of previ-
ously described Foxp3null mice lacking Treg cells and of
Foxp3DTR mice subjected to the diphtheria-toxin-mediated
Treg cell ablation (Fontenot et al., 2003; Kim et al., 2007). To fur-
ther explore the question, we sensitized Il10flox/flox3 Foxp3YFP-Cre
and control Il10WT/flox 3 Foxp3YFP-Cre mice by painting the skin
at the shaved abdomen region with dinitrofluorobenzene
(DNFB) and challenged them by application of DNFB on one
ear; the other ear was treated with the vehicle as a control. Theindicated subsets of purified CD4 T cells from Il10flox/flox3 Foxp3YFP-Cre (fl/fl) and Il10WT/flox3 Foxp3YFP-Cre mice (fl/wt) (results of one representative experiment
are shown).
(B) Bar graphs show relative intensity of the indicated PCR products normalized to the intensity of the Foxp3 band used as a control PCR product. The results
represent one of two identical experiments.
(C) Cellularity of the thymus and secondary lymphoid organs in 8- to 10-week-old mice is unaffected by the IL-10 ablation in Treg cells. Each symbol represents
mononuclear cell number in the thymus (Thy), spleen (Spl), lymph nodes (LN), and colon-draining mesenteric lymph nodes (MLN) in individual Il10flox/flox 3
Foxp3YFP-Cre (open symbols) and Il10WT/flox 3 Foxp3YFP-Cre mice (closed symbols). LN cell counts represent pooled lymph nodes excluding MLN.
(D) Flow-cytometric analysis of splenic and lymph node T cell subsets in Il10flox/flox3 Foxp3YFP-Cre and Il10WT/flox3 Foxp3YFP-Cre mice. Twelvemicewere analyzed
in three independent experiments.
(E) Flow-cytometric analysis of expression of activation markers by splenic and lymph node T cells in 5- to 8-week-old Il10flox/flox3 Foxp3YFP-Cre and Il10WT/flox3
Foxp3YFP-Cre mice. Cells were stained for CD4, CD8, CD25, CD62L, and CD44. Gate for YFP-CD4+ cells is shown. Twelve mice were analyzed in three
independent experiments.
(F) Analysis of intracellular cytokine expression in total splenocytes stimulated with plate-bound CD3 and CD28 antibodies. Splenocytes were isolated from 6- to
8-week-old Il10flox/flox3 Foxp3YFP-Cre and Il10WT/flox3 Foxp3YFP-Cre mice and after 5 hr activation were stained for CD4, CD8, IL-2, IL-4, IFNg, and TNFa. The data
are shown as mean percentages (± standard error) of cytokine-positive cells in CD4+ or CD8+ populations in individual mice. Unstimulated cell samples cultured
in the absence of antibodies are shown as a control. Eight animals per group were analyzed in two separate experiments.Immunity 28, 546–558, April 2008 ª2008 Elsevier Inc. 551
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Colitis in Il10flox/flox 3 Foxp3YFP-Cre Mice
(A) Representative formalin-fixed and hematoxy-
lin- and eosin-stained sections from the cecum
(top row), colon (middle row), and small intestines
(bottom row) of approximately 3-month-old wild-
type, germ-line, and Treg cell-restricted IL-10-
deficient mice. The littermate control Il10WT/flox 3
Foxp3YFP-Cre sections are within normal limits
(left column). The Il10flox/flox3 Foxp3YFP-Cre cecum
and colon have relatively moderate inflammatory
bowel disease-type lesions characterized by mild
mucosal hyperplasia and inflammation within the
mucosa and submucosa. Compare to the severe
lesions characterized bymarkedmucosal thicken-
ing, hyperplasia, glandular loss, crypt abscesses,
submucosal edema, and transmural inflammation
in the Il10/ mice. In all animals the small-intesti-
nal regions are within normal limits. Original
magnification for all images, 103.
(B) IBD scores of the small and large intestines and
cecum of approximately 3-month-old Il10flox/flox3
Foxp3YFP-Cre, littermate control Il10WT/flox 3
Foxp3YFP-Cre, and Il10/ mice. Formalin-fixed
sections were stained with H&E prior to examina-
tion. Mean pathology scores ± standard error are
shown; there were 3–6 mice per group.
(C) Incidence of clinical colitis in Il10flox/flox 3
Foxp3YFP-Cre and Il10/mice. Animals were mon-
itored daily for clinical signs of colitis, including
rectal prolapse and diarrhea. Colitis was further
confirmed by macroscopic examination of the
colon and selective tissue histopathology. Num-
ber of animals in each cohort: Il10flox/flox 3
Foxp3YFP-Cre, 140; Il10WT/flox 3 Foxp3YFP-Cre,
128; and Il10/, 42.
(D) Flow-cytometric analysis of colonic Foxp3+
Treg cells in Il10flox/flox 3 Foxp3YFP-Cre mice. Co-
lonic IEL and LPL were isolated from three mice
of each indicated genotype, pooled, and stained
for CD4, CD8, TCRb, and Foxp3. Gate for
CD4+CD8-TCRb+ cells is shown. A representative
of two independent experiments is shown.ensuing skin hypersensitivity reaction was assessed by ear
thickness measured before and after the challenge. We found
a substantial increase in ear thickness and heightened inflamma-
tion in Il10flox/flox3 Foxp3YFP-Cre mice as compared to the control
animals (Figures 6A and 6B). To examine whether the increased
skin hypersensitivity in Il10flox/flox 3 Foxp3YFP-Cre mice was due
to Treg cell homing deficiency, i.e., the inability to home to the
skin, or due to their impaired suppressor capacity, we examined
CD4+ T cell subsets in the ears of the mutant mice. As in analo-
gous analyses of lung and colon tissue, we found the same pro-
portion of the FoxP3+ CD4+ T cells in the skin of mutant and con-
trol mice (Figure 6C). It is noteworthy that the expression of the T
cell activation marker CD69 on non-Treg cells was higher in mu-
tant mice than in control mice (data not shown). Thus, Treg cells552 Immunity 28, 546–558, April 2008 ª2008 Elsevier Inc.lacking IL-10 production are not as effective in controlling inflam-
mation in skin as their IL-10-sufficient counterparts. Together,
our studies suggest that the production of IL-10 by Treg cells
is limiting inflammation at environmental interfaces and is at
the same time dispensable for control of systemic autoimmunity.
DISCUSSION
Foxp3-expressing Treg cells play a central role in immunological
tolerance to self and environmental antigens and in limiting
tissue damage associated with the immune response to patho-
gens. Recent reports have suggested that Treg cells are capable
of controlling the activation of a variety of immune cell types, in-
cluding CD4+ and CD8+ T cells, B cells, NK cells, dendritic cells,
Immunity
Treg Cell-Derived IL10 Limits Inflammationand macrophages. Furthermore, numerous mechanisms were
proposed to be responsible for Treg cell-mediated suppression;
these included production of immunomodulatory cytokines
IL-10 and TGF-b (Asseman et al., 1999; Chen et al., 2005),
CTLA-4-mediated cross-linking of B7 molecules on the surface
of activated T cells or APC (Oderup et al., 2006; Paust et al.,
2004; Tang et al., 2004), elaboration of extracellular adenosine
through the cooperative action of ectonucleotidases CD39 and
CD73 (Deaglio et al., 2007), extrusion of cAMP (Bopp et al.,
2007), and cytolytic activity mediated by granzymes (Gondek
Figure 4. Minor Peribronchial Inflammation and a Normal Size of the
Foxp3+ Treg Cell Subset in the Lungs of Unmanipulated Il10flox/flox3
Foxp3YFP-Cre Mice
(A) Histology sections of lungs from mice with a Treg cell-restricted IL-10
deficiency. Formalin-fixed sections of lungs of approximately 3-month-old
Il10flox/flox 3 Foxp3YFP-Cre and littermate control Il10WT/flox 3 Foxp3YFP-Cre
mice were stained with H&E. Original magnification, 103.
(B) Flow-cytometric analysis of Foxp3+ Treg cells in the lung tissue of
Il10flox/flox 3 Foxp3YFP-Cre and littermate control Il10WT/flox 3 Foxp3YFP-Cre
mice. A lung-resident population of mononuclear cells was isolated from
PBS-perfused lungs. Cells isolated from three mice of each genotype were
pooled and stained for CD4, CD8, CD25, and Foxp3. The CD4+CD8 T cell
gate is shown. A representative of two identical experiments is shown.et al., 2005) as well as several additional hypothetical mecha-
nisms (Mahic et al., 2006). However, an unequivocal proof of
a unique or non-redundant role for any of the abovemechanisms
in regulatory T cell-mediated suppression in un-manipulated
mice has been lacking.
Recent studies have established that the suppressor function
of regulatory T cells is critically dependent upon expression of
the Foxp3 protein. This conclusion is supported by a loss of sup-
pressor function by genetically marked T cells transcribing the
Foxp3 locus yet lacking in functional Foxp3 protein expression
in mice with the targeted insertion of GFP into the Foxp3 locus
(Gavin et al., 2007; Lin et al., 2007). Furthermore, a decreased
Foxp3 protein expression in Treg cells as a result of induced
dysregulation of Foxp3 gene transcription resulted in a marked
attenuation of the suppressor function (Wan and Flavell, 2007).
In agreement with these results, the Foxp3 ablation in mature
Treg cells through the Cre-mediated deletion of a conditional
Foxp3 allele results in a loss of suppressor function (Williams
and Rudensky, 2007). Genome-wide analyses of Foxp3 binding
sites utilizing ex vivo-isolated mouse Treg cells or the Foxp3
transfected hybridoma cell line revealed a relatively small num-
ber of directly Foxp3-regulated genes, including few genes
encoding putative effector molecules, e.g., CTLA4 and Nt5e
(Marson et al., 2007; Zheng et al., 2007). In light of these results,
it is reasonable to speculate that Foxp3 induces expression of
a unique gene mediating suppressor function of Treg cells.
Mice lacking such a gene are expected to develop a rapid and
fatal autoimmune syndrome analogous to that described in
Foxp3DTR mice subjected to chronic Treg cell ablation (Kim
et al., 2007). Alternatively, it is possible that Treg cells employ
multiple immunomodulatory or suppressive molecules, not nec-
essarily unique to Treg cells, that are employed by these cells
with a great deal of efficiency as a result of a superior proliferative
and metabolic potential, as well as a migratory capacity be-
stowed by Foxp3 (Gavin et al., 2002; Gavin et al., 2007; Kim
et al., 2007; Komatsu and Hori, 2007; Zheng et al., 2007). It is
reasonable to speculate that a given suppressive mechanism
might operate in a particular inflammatory-tissue setting. A cor-
ollary to this scenario is that spontaneous inflammatory lesions
resulting from a deficiency in a single effector mechanism will
be much less severe and pervasive than those resulting from
a lack of the entire Treg cell subset.
As discussed above, pioneering studies by Powrie and
coworkers implicated IL-10 in Treg cell-mediated suppression
of induction of immune-mediated colitis. These studies relied on
adoptive T cell transfer into lymphopenic hosts and antibody-
mediated neutralization of IL-10 or IL-10R (Annacker et al.,
2003; Asseman et al., 1999; Asseman et al., 2003; Singh et al.,
2001). Furthermore, provision of IL-10-sufficient but not IL-10-
deficient CD25+CD4+ T cells resolves the established intestinal
inflammation (Uhlig et al., 2006). A priori IL-10 cannot be a unique
suppressor molecule utilized by Treg cells. Within the immune
system, multiple cell types, including B cells, T cells, mast cells,
and dendritic cells, produce IL-10 (Moore et al., 2001). Func-
tional significance of IL-10 production by diverse cell types
was highlighted by recent observations of an important role
for mast cell-derived IL-10 in cutaneous hypersensitivity reac-
tions induced upon immunization or chronic UV irradiation (Grim-
baldeston et al., 2007). The germ-line deletion of the Il10 geneImmunity 28, 546–558, April 2008 ª2008 Elsevier Inc. 553
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rapid disease observed in Foxp3 mutant mice (Berg et al.,
1995; Fontenot et al., 2003; Kuhn et al., 1993). Importantly, we
previously reported that the ablation of the Il10 gene in T cell
lineage results in a comparably severe colitis, increased skin
hypersensitivity, and the fatal immunopathology associated
Figure 5. Increased Lung Allergic Inflam-
mation and Hyperreactivity in Il10flox/flox 3
Foxp3YFP-Cre Mice
(A) Increased number of leukocytes in BAL fluid of
OVA primed Il10flox/flox 3 Foxp3YFP-Cre mice in-
duced upon OVA or saline (control) challenge. Cel-
lular composition of BAL fluid was examined as
described in the Experimental Procedures. The
data represent mean BAL leukocyte number ±
standard error (n = 8 per group in each of three
independent experiments).
(B) Histopathology of lungs isolated from OVA-
challenged Il10flox/flox 3 Foxp3YFP-Cre and litter-
mate control Il10WT/flox 3 Foxp3YFP-Cre mice.
Mice primed with OVA or saline (control) were
rechallenged upon intranasal administration of
OVA or saline. A representative of five mice per
group from three independent experiments is
shown. Original magnification, 403.
(C) Augmented lung resistance in OVA-challenged
Il10flox/flox 3 Foxp3YFP-Cre mice. Methacholine-in-
duced lung resistance was measured via invasive
plethysmography in OVA-challenged Il10flox/flox 3
Foxp3YFP-Cre and littermate control Il10WT/flox 3
Foxp3YFP-Cre mice (n = 4–5 per group). The data
are shown as the mean n-fold change of RL values
(± standard error) as compared tomice not treated
with methacholine. A representative of three inde-
pendent experiments is shown.
with Toxoplasma gondii infection (Roers
et al., 2004). However, within the T cell lin-
eage, multiple T cell subsets other than
Treg cells, including NKT cells, Foxp3
Tr1 cells, and conventional IFN-g-pro-
ducing effector CD4+ T cells elicited in
the course of immune response to a path-
ogen such as Toxoplasma gondii or
Leishmania major, can serve as a major
source of IL-10 production (Anderson
et al., 2007; Jankovic et al., 2007; Nylen
et al., 2007; Roers et al., 2004). Therefore,
elucidation of a functional significance of
IL-10 production by Treg cells in control
of immune inflammation in unmanipu-
lated mice should provide an acid test
for the aforementioned opposing models
of Treg cell-mediated suppression.
Here, through the ablation of a condi-
tional Il10 allele in Treg cells, and using
Cre recombinase knocked into the 30
UTR of the Foxp3 locus, we found that
IL-10 plays a prominent role in Treg cell
suppressive function in the colon, lung,
and skin. Consistent with the recent findings that some IL-10-ex-
pressing T cells in the colonic lamina propria (and the majority of
these cells in the small intestine) do not express Foxp3, sponta-
neous intestinal inflammation was largely limited to the colon,
and its severity was less pronounced in Foxp3YFP-Cre mice than
in mice with the germ-line or T cell-specific IL-10 deficiency554 Immunity 28, 546–558, April 2008 ª2008 Elsevier Inc.
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Treg Cell-Derived IL10 Limits InflammationTable 1. Morphometric Analysis of Antigen-Induced Lung Inflammation in IL10 3 Foxp3YFP-Cre Mice
Lung Pathology Score
Il10WT/flox 3 Foxp3YFP-Cre Il10flox/flox 3 Foxp3YFP-Cre
Saline/Saline OVA/OVA Saline/Saline OVA/OVA
Total Inflammatory Cell Infiltrate in Lungs (0–4+) 0.0 ± 0.0 2.3 ± 0.3 0.05 ± 0.05 3.7 ± 0.3a
Eosinophil infiltrate (eosinophils/unit of lung tissue area) 0.1 ± 0.1 15.9 ± 0.1 0.25 ± 0.19 23.4 ± 2.4a
Mucus occlusion of airway diameter (0–4+) 0.1 ± 0.06 2.4 ± 0.1 0.05 ± 0.05 3.7 ± 0.2a
Goblet cells (percent of airway epithelial cells) 0.1 ± 0.06 24.0 ± 4.2 0.05 ± 0.05 38.7 ± 5.3a
Airway edema (0–4+) 0.1 ± 0.06 1.4 ± 0.2 0.05 ± 0.05 2.4 ± 0.3a
Ten sections per mousewere evaluated on a 0–4+ scale. The data are presented as themean score (± standard error). Eight to tenmice per groupwere
analyzed in two independent experiments.
a p values of the differences betweenmean scores for OVA-treated Il10flox/flox3 Foxp3YFP-Cre and Il10WT/flox3 Foxp3YFP-Cre mice were between 0.0001
and 0.0156.(Kamanaka et al., 2006; Maynard et al., 2007; Roers et al., 2004).
In contrast to spontaneous colonic inflammation, unchallenged
Il10flox/flox3 Foxp3YFP-Cre micemaintained under SPF conditions
showed very little immune-mediated inflammation in the skin or
lungs (data not shown). Nevertheless, upon induction of local an-
tigen-specific immune responses, a markedly enhanced inflam-
mation and tissue pathology was observed in the absence of
Treg cell-derived IL-10 in the experimental models of the skin
and lung hypersensitivity. Interestingly, in contrast to a sharp
increase in airway resistance in OVA-challenged Il10flox/flox 3
Foxp3YFP-Cre mice, the airway resistance was not markedly aug-
mented in Il10/mice in comparison to wild-typemice (data not
shown). The latter observation is in agreement with another
study of Il10/mice (Makela et al., 2000); this study also utilized
OVA-induced lung inflammation. Lack of lung hyper-reactivity in
Il10/mice can be explained by previously proposed regulation
of smooth-muscle contraction by IL-10 originating from cells
other than Treg cells (Makela et al., 2000). In addition, it is possi-
ble that a more prominent profuse colitis in mice with the germ-
line IL-10 deficiency than in mice in which the IL-10 deficiency
limited to Treg cells results in amassive focus of intestinal inflam-
mation, ‘‘detracting’’ pro-inflammatory cells from the lung. We
further speculate that this observation of ‘‘immune detraction’’
in themodel of induced lung hypersensitivity might be applicable
to other types of immune inflammation.
It is noteworthy that the acquisition of IL-10 production by Treg
cells, a particular, functionally important suppressor modality, is
likely to be facilitated by the environment at mucosal interfaces.
This notion comes from the observations that despite the fact
that IL-10 expression can be found in a subset of Foxp3+ Treg
cells present in tissues such as colon or lung, Foxp3-expressing
thymocytes lack IL-10 expression.
Our studies demonstrate that IL-10 produced by Treg cells is
not required for limiting systemic autoimmunity but is needed
for restraining immunological hyperreactivity at environmental
interfaces. In contrast, CTLA-4 ablation in Treg cells resulted in
systemic lymphoproliferative syndrome and severe pancreatic
lesions, whereas the colon and skin remained largely unaffected
(Y.P.R., A. Paterson, A. Sharpe, and A.Y.R., unpublished obser-
vations). These results strongly suggest that Tregcells utilizemul-
tiple means to limit the immune response and that suppressive
mechanisms utilized by Treg cells are likely to be nonredundant,
or only partially redundant, with individual suppressor mecha-
nisms operating in a particular tissue and inflammatory setting.EXPERIMENTAL PROCEDURES
Mice
Il10flox/flox mice have been described elsewhere (Roers et al., 2004). Il10/ an-
imals were purchased from the Jackson Laboratory. Il10flox/flox mice were on
the C57BL/6 background, whereas Foxp3YFP-Cre mice, originally on a mixed
B6/129 background, were backcrossed onto the C57BL/6J background three
to four times in the process of generating Il10flox/flox 3 Foxp3YFP-Cre mice. All
mice were maintained in the University of Washington specific pathogen-
free facility that was Helicobacter species positive and handled in accordance
with the institutional guidelines for animal care and use.
Generation of the Targeted Foxp3YFP-Cre Allele
A7.9 kilobase (kb) XbaI fragment of the Foxp3 locus containing exons 6 through
11 was subcloned from a 30.8 kb cosmid containing the complete Foxp3 gene
into a pBluescript vector containing a PGK-DTA-negative selection cassette.
A SalI restriction site was engineered in place of the BaeI site present in the
30 UTR region of the Foxp3 gene, upstream of the polyadenylation signal. To
generate the targeting construct, we cloned IRES-YFP-Cre-BGHpA-FRT-
Neo-FRT cassette provided by Richard Locksley (UCSF) into the SalI site.
The linearized targeting constructwaselectroporated intoR1EScells, andneo-
mycin-resistant cloneswere screenedbyPCRacross the 30 arm for evidence of
the homologous recombination. Positive clones were further screened by
Southern blot analysis of BspHI-digested genomic DNA. ES cell clones harbor-
ing the correctly targeted Foxp3 locus were injected into C57BL/6 blastocysts,
and chimeric male offspring weremated to the FLP-deleter transgenic strain of
mice so that the PGK-Neo cassette would be excised. Germ-line transmission
of the targeted allele was confirmed by PCR with genomic tail DNA.
PCR Confirmation of the Deletion of the Il10flox Allele
Genomic DNA from sorted T cells was isolated with DNeasy Blood & Tissue
Kit (QIAGEN) and diluted to a final concentration 5 ng/ml in Tris-EDTA buffer
(pH 7.4). Serial dilutions of template were used in PCR with two pairs of Il10-
specific primers: 50-ACTGGCTCAGCACTGCTATGC-30 and 50-GCCTTCTTT
GGACCTCCATACCAG-30 for detecting Il10flox or Il10wt alleles; 50-CAGGATTT
GACAGTGCTAGAGC-3 and 50-AAACCCAGCTCAAATCTCCTGC-30 for de-
tecting the Il10 allele lacking excised floxed fragment. To normalize the amount
of input DNA, we used PCR with primers to the Foxp3 gene: 50-AGACAGAC
CAGAGGTGTAGT-30 and 50-TCCTGGGGATGGGCCAAGGGCCAAGG-30.
Preparation of Single-Cell Lymphocyte Suspensions
from the Lung, Colon, and Skin
Prior to collection, lungs were perfused with 10 ml PBS and minced with scis-
sors. After addition of 10ml DMEM, 5% FCS, collagenase D (Roche, 2 mg/ml),
and DNase (30 mg/ml), tissue fragments were incubated at 37C for 30 min in
an orbital shaker, collected by centrifugation, resuspended in HBSS, 5 mM
EDTA, and 5% FCS for 5 min at 37C with shaking, and filtered through
a 100 mm cell strainer. Cells were washed twice with PBS and subjected to
flow-cytometric analysis. Lymphocyte-containing cell suspension from the
total colon was prepared according to a modified protocol (Drakes et al.,Immunity 28, 546–558, April 2008 ª2008 Elsevier Inc. 555
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Treg Cell-Derived IL10 Limits InflammationFigure 6. Increased Contact Hypersensitivity Reaction in Il10flox/flox 3 Foxp3YFP-Cre Mice
(A) Increased ear thickness in Il10flox/flox 3 Foxp3YFP-Cre mice as compared with Il10WT/flox 3 Foxp3YFP-Cre littermate controls 48 hr after challenge with DNFB.
Ear thickness was measured with a caliper prior to and 48 hr after antigenic challenge. The data are shown as the percent increase in ear thickness compared
to thickness of the same ear before it was painted with DNFB. Twelve mice were used per group in each of two independent experiments.
(B) Histology sections of skin (ears) challenged with DNFB so that a skin-contact hypersensitivity reaction would be induced in sensitized littermate control
Il10WT/flox 3 Foxp3YFP-Cre and Il10flox/flox 3 Foxp3YFP-Cre mice. Formalin-fixed sections stained with hematoxylin and eosin from the same region of the pinnae
are presented. Note marked subcutaneous expansion of the Il10flox/flox 3 Foxp3YFP-Cre pinnae by edema with inflammatory cells. Original magnification, 103.
Inset: higher magnification of Il10flox/flox 3 Foxp3YFP-Cre. Note dilated lymphatic and inflammatory cells (arrows) next to a smooth-muscle cell (asterix). Original
magnification, 603.
(C) Frequency of Foxp3+ Treg cells in the skin at the site of antigenic challenge is not changed in Il10flox/flox3 Foxp3YFP-Cre mice as compared to littermate con-
trols. Flow-cytometric analysis of skin T cell subsets isolated from the DNFB-painted ears of Il10flox/flox 3 Foxp3YFP-Cre and Il10WT/flox 3 Foxp3YFP-Cre mice.
Expression of Foxp3 in the CD4+CD8 T cell gate is shown.2005). Lymphocyte-containing cell populations were isolated from the ear skin
as described (Ohl et al., 2004).
Cell Purification and Flow-Cytometric Analysis of T Cell Subsets
and Cytokine Production
Cell populations were purified with magnetic beads and an AutoMACS mag-
netic cell sorter (Miltenyi Biotec) or with a FACSAria fluorescent cell sorter
(BD Biosciences). The purity of all cell preparations was >90%. Flow-cytomet-
ric analyses were carried out with a FACSCanto flow cytometer (BD Biosci-
ences). Fluorochrome-conjugated mouse CD4, CD8a, CD44, CD69, CD62L,
CD25, and Foxp3 antibodies (BD Biosciences or eBioscience) were used.
Flow-cytometric analysis of cytokine production was performed as described
elsewhere (Williams and Rudensky, 2007). For IL-10 secretion analysis, cells556 Immunity 28, 546–558, April 2008 ª2008 Elsevier Inc.were plated in round-bottom plates at 5 3 105/ml in 0.2 ml of RPMI/10%
FCS. LPL cells were stimulated in vitro with PMA (100 ng/ml) and ionomycin
(1 mg/ml) for 4 hr in the presence of Golgi Plug (BD PharMingen). Splenocytes
were stimulated with plate-bound CD3 and CD28 antibodies (1 mg/ml each) for
72 hr in the presence of rhTGF-b1 (2 ng/ml) and IL-2 (100 U/ml) and restimu-
lated for 4 hr with PMA and ionomycin (50 ng/ml and 500 ng/ml, respectively)
in the presence of Golgi Plug. Stimulated and unstimulated control cells were
stained for surface expression of CD4, FoxP3, and IL-10 antibodies according
to the manufacturer’s (eBioscience’s) protocol.
Histopathological Evaluation of Spontaneous Colitis
Samples of small intestine, cecum, and colon from 3–4 animals per group were
fixed in 10% neutral buffered formalin and processed routinely for hematoxylin
Immunity
Treg Cell-Derived IL10 Limits Inflammationand eosin staining. Histological evaluation of colitis within the cecum and prox-
imal and mid-colon was performed as described previously (Burich et al.,
2001), except that the small intestine was included. In brief, a pathologist
blinded to genotype and using a 0–4 scale scored mucosal changes (erosion,
ulceration, and/or hyperplasia), inflammation, and extent of section involve-
ment. An inflammatory bowel disease (IBD) score was generated from the
sum of the individual section scores.
Induction of Allergic Lung Inflammation and Evaluation of Lung
Function and Lung Histopathology
Mice received two i.p. injections of 100 mg OVA (Pierce Chemical Co.) com-
plexed with aluminum potassium sulfate (alum; Sigma-Aldrich) in 0.2 ml on
days 1 and 14. Mice were anesthetized by administration of 130 mg/kg ket-
amine and 8.8 mg/kg xylazine in saline prior to intranasal (i.n.) challenge with
100 mg OVA (0.05 ml; 2 mg/ml) on day 14 and with 50 mg OVA (0.05 ml;
1mg/ml) on day 25 (Henderson et al., 1996; Zhang et al., 1997). Control groups
ofmice received 0.2ml saline with alum i.p. on days 1 and 14 and 0.05ml saline
without alum i.n. on days 14 and 25. For BAL cell isolation, the right lung was
lavaged three times with 0.5 ml of normal saline 24 hr after the final OVA or
saline treatment, and cells were analyzed as described (Henderson et al.,
1996).
To evaluate pulmonary function, we measured invasive pulmonary mechan-
ics in mice in response to methacholine as previously described (Henderson
et al., 2007; Henderson et al., 1996), except the thorax was not opened.
Lung pathology evaluation was performed in a blinded fashion as described
elsewhere (Henderson et al., 2005) (for a detailed description, see Supplemen-
tal Data).
Real-Time PCR
Total RNA was isolated from the right lung with an RNeasy mini kit (QIAGEN),
and mRNA amounts for IL-4, IL-5, IL-13, IFN-g, and GAPDH were determined
by quantitative PCR on a 7900HT instrument (Applied Biosystems). For design
of all primers, Primer 3 softwarewas used across the intronic sequences (Table
S1). PCR product sizes of 100 bp were confirmed by gel electrophoresis.
Skin-Contact Hypersensitivity Reaction
We induced skin hypersensitivity by painting the shaved abdomen with 100 ml
0.5% (wt/vol) dinitrofluorobenzene (DNFB; Sigma-Aldrich) in a 4:1 mixture of
acetone and olive oil for sensitization. The mice were challenged 6 days later
by application of 10 ml 0.2% (wt/vol) DNFB in olive oil to each side of one
ear. Ear thickness was determined with an engineer’s caliper (Mitutoyo) before
challenge and at 48 hr after treatment. The percent increase of ear thickness
was compared for the different experimental groups with the Student’s t test
for independent samples (Roers et al., 2004). We performed routine formalin
fixation and processing on selected animals to characterize the histopatho-
logical lesions.
SUPPLEMENTAL DATA
One table, five figures, and additional Experimental Procedures are available
online at http://www.immunity.com/cgi/content/full/28/4/546/DC1/.
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